The Age-Related Macular Degeneration Drug Market: A Growing Opportunity in Vision Care
%20Drug%20Market.%20The%20design%20includes%20sections%20with%20icons%20and%20text_%201)%20Product%20Types.webp)
Age-related macular degeneration (AMD) has emerged as one of the most significant challenges in ophthalmology, affecting millions of people worldwide and driving substantial growth in the pharmaceutical industry. As the global population ages, the Age-Related Macular Degeneration (AMD) drug market is experiencing unprecedented expansion, presenting both opportunities and challenges for patients, healthcare providers, and pharmaceutical companies. Request a Sample: https://www.futurewiseresearch.com/contact.aspx?rpt=3924&type=requestsample Market Size and Growth Trajectory The AMD drug market has demonstrated remarkable growth momentum in recent years. The global age-related macular degeneration market size was valued at USD 10.82 billion in 2023 and is projected to grow at a CAGR of 8.2% from 2024 to 2030. Other market analyses project even stronger growth, with some forecasts suggesting the global AMD drugs market is set to grow from USD 10.46 billion in 2024 to USD 17...